Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 5/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 2/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
| ▸ | KDR | P35968 | 2/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | STS | P08842 | 1/20 | 0.32 |
| ▸ | ELOVL6 | Q9H5J4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21610777 | 0.79 | PTGS2 (0.37) | — | |
| SCHEMBL21610807 | 0.78 | ALDH1A1 (0.36) | TACR1GAA | |
| SCHEMBL8486996 | 0.73 | HTR2C (0.45) | TACR1CNR1 | |
| SCHEMBL437277 | 0.72 | TACR1 (0.42) | TACR1S1PR1 | |
| SCHEMBL10629252 | 0.72 | TACR1 (0.39) | TACR1S1PR1 | |
| SCHEMBL17806594 | 0.71 | AKR1C3 (0.41) | KCNH2HPGDELOVL6 | |
| SCHEMBL10207483 | 0.71 | PTGS2 (0.40) | EPHX1CNR1ELOVL6 | |
| SCHEMBL11951572 | 0.70 | MCOLN3 (0.51) | GAACNR1ELOVL6 | |
| SCHEMBL18353236 | 0.69 | NOTUM (0.43) | TACR1CNR1 | |
| SCHEMBL21610758 | 0.69 | TACR1 (0.36) | KCNH2TACR1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143596-A1 | PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-11 | — | — | US | disclosed |
| US-20230143596-A1 | PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-11 | — | — | US | disclosed |
| WO-2021037614-A1 | PESTICIDALLY ACTIVE PYRAZINE-AMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2021-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143596-A1 | PESTICIDALLY ACTIVE DIAZINE-BISAMIDE COMPOUNDS | DDT, ACHE, NIT2 | KCNH2 538/4885TACR1 2209/4885CCR6 4807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.